Combined with pembrolizumab and binimetinib (a small molecule inhibitor), the study tried to assess the ability of MAPK and VEGF pathway blockade to overcome resistance to immunotherapy in microsatellite stable metastatic colorectal cancer. The gene discussed is VEGFA; the disease is metastatic colorectal cancer.